Collectively, these data suggest that DIM significantly inhibits cardiac hypertrophy through directly stimulating p-AMPKα activity and inhibiting the mTOR/p70S6K signaling pathway. The gene discussed is RPS6KB1; the disease is cardiac hypertrophy.